Journal
CURRENT GENE THERAPY
Volume 12, Issue 5, Pages 423-436Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/156652312802762590
Keywords
Brain gene delivery; cell vehicles; exosomes; non-viral vectors; vehicles; viral vectors
Categories
Funding
- National Pharmaceutical Program [2009ZX09503-028]
- Science and Technology Pillar Program of Jiangsu Province [BE2010719]
- Fundamental Research Funds for the Central Universities [1107020836, 1118020806]
- Research Fund for the Doctoral Program of Higher Education of China [20110091120044]
- Natural Science Foundation of Jiangsu [BK2011572]
- National Natural Science Foundation [30973651]
- Changzhou Special Project of Biotechnology and Biopharmacy [CE20105006]
Ask authors/readers for more resources
Gene therapy is a novel and promising treatment strategy for brain diseases. Yet, its development is largely obscured by various in vivo transport hurdles, especially the special BBB structure of brain. Developing an ingenious delivery vehicle can provide a great solution. Conventional vehicles for brain gene delivery are viral and non-viral vectors. With inherent superiority of gene transfection, researches on viral vectors are mainly focused on problems of brain cell targeting and global brain delivery. Non-viral vectors are more studied for better brain cell entrance either directly delivered to brain or systemically delivered to the body. Novel vehicles are cell vehicles (genetically engineered or nanoparticle-carrying cells) and exosomes. They exhibit distinct and unique features compared to viral and non-viral vectors. This review gives a summarization of current advances in these four kinds of brain gene vehicles. The merits and demerits of them are also pointed out respectively. We are hoping to give a clue to the future development direction of vehicles for brain gene delivery.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available